1CM
ITCI

1492 Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

1492 Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-52,537
Closed -$4.39M – 130
2024
Q4 		$4.39M Sell
52,537
-322
-0.6% -$26.5K 2.09% 17
2024
Q3 		$3.87M Sell
52,859
-261
-0.5% -$19.6K 1.93% 19
2024
Q2 		$3.64M Buy
53,120
+17,857
+51% +$1.24M 2.06% 18
2024
Q1 		$2.44M Sell
35,263
-30
-0.1% -$2.06K 1.36% 31
2023
Q4 		$2.53M Buy
35,293
+361
+1% +$20.8K 1.44% 25
2023
Q3 		$1.82M Hold
34,932
– – 1.17% 29
2023
Q2 		$2.21M Sell
34,932
-17
-0% -$1.06K 1.29% 27
2023
Q1 		$1.89M Sell
34,949
-12
-0% -$580 1.17% 29
2022
Q4 		$1.85M Hold
34,961
– – 1.19% 27
2022
Q3 		$1.63M Buy
34,961
+10,891
+45% +$569K 1.17% 28
2022
Q2 		$1.37M Buy
+24,070
New +$1.36M 0.9% 38

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return